ES2121941T3 - Soluciones de dialisis peritoneal y metodos utiles para reducir las lesiones y los efectos psicologicos negativos producidos por la peritonitis. - Google Patents

Soluciones de dialisis peritoneal y metodos utiles para reducir las lesiones y los efectos psicologicos negativos producidos por la peritonitis.

Info

Publication number
ES2121941T3
ES2121941T3 ES93300846T ES93300846T ES2121941T3 ES 2121941 T3 ES2121941 T3 ES 2121941T3 ES 93300846 T ES93300846 T ES 93300846T ES 93300846 T ES93300846 T ES 93300846T ES 2121941 T3 ES2121941 T3 ES 2121941T3
Authority
ES
Spain
Prior art keywords
peritonitis
peritoneal dialysis
effects produced
useful methods
dialysis solutions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93300846T
Other languages
English (en)
Inventor
Andrzej Breborowicz
Dimitrios G Oreopulos
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baxter International Inc
Original Assignee
Baxter International Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter International Inc filed Critical Baxter International Inc
Application granted granted Critical
Publication of ES2121941T3 publication Critical patent/ES2121941T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/28—Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
    • A61M1/287—Dialysates therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A61K38/446—Superoxide dismutase (1.15)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Emergency Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • External Artificial Organs (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

LAS SOLUCIONES PARA DIALISIS PERITONEAL ESTAN FORMULADAS ESPECIALMENTE PARA USAR DURANTE E INMEDIATAMENTE DESPUES DE UN PROCESO DE PERITONITIS. LAS SOLUCIONES INCLUYEN UNO O MAS ADITIVOS PARA REDUCIR LAS LESIONES Y EFECTOS FISIOLOGICOS QUE LA PERITONITIS PUEDE CAUSAR. UN ADITIVO ES UNA MEZCLA DE ACIDOS AMINO SUFICIENTE PARA MANTENER UN EQUILIBRIO POSITIVO DE NITROGENO, AL MENOS UNO DE LOS ACIDOS AMINO QUE ESTAN PRESENTES EN FORMA DIPEPTIDA. OTRO ADITIVO ES UN COMPUESTO QUE EXPULSA RADICALES LIBRES GENERADOS POR MACROFAGOS PERITONEALES ACTIVADOS POR LA PERITONITIS. OTRO ADITIVO ES SULFATO DE CONDROITINA QUE CAMBIA LA PERMEABILIDAD DE LA MEMBRANA PERITONEA DURANTE LA DIALISIS POSTERIOR USANDO SOLUCIONES LIBRES DE SULFATO DE CONDROITINA. OTRO ADITIVO ES EL PRODUCTO DE DEGRADACION DEL ACIDO HIALURONICO PARA REFORZAR LA REGENERACION DEL MESOTELIO PERITONEAL SIN FIBROSIS.
ES93300846T 1992-02-04 1993-02-04 Soluciones de dialisis peritoneal y metodos utiles para reducir las lesiones y los efectos psicologicos negativos producidos por la peritonitis. Expired - Lifetime ES2121941T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US83072192A 1992-02-04 1992-02-04

Publications (1)

Publication Number Publication Date
ES2121941T3 true ES2121941T3 (es) 1998-12-16

Family

ID=25257564

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93300846T Expired - Lifetime ES2121941T3 (es) 1992-02-04 1993-02-04 Soluciones de dialisis peritoneal y metodos utiles para reducir las lesiones y los efectos psicologicos negativos producidos por la peritonitis.

Country Status (8)

Country Link
US (2) US5597805A (es)
EP (2) EP0804931B1 (es)
JP (1) JP3262620B2 (es)
AT (2) ATE169223T1 (es)
DE (2) DE69320078T2 (es)
DK (1) DK0555087T3 (es)
ES (1) ES2121941T3 (es)
GR (1) GR3027714T3 (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1340994C (en) * 1989-09-21 2000-05-16 Rudolf Edgar Dr. Falk Treatment of conditions and disease
ES2121941T3 (es) * 1992-02-04 1998-12-16 Baxter Int Soluciones de dialisis peritoneal y metodos utiles para reducir las lesiones y los efectos psicologicos negativos producidos por la peritonitis.
KR100309972B1 (ko) * 1992-12-22 2001-12-28 데이비드 씨. 맥키, 토마스 제어. 시바티노 복막투석환자치료용의개량아미노산용액
CA2155910C (en) * 1995-08-11 1999-12-14 George Wu Biocompatible aqueous solution for use in continuous ambulatory peritoneal dialysis
JP2001513370A (ja) 1997-08-07 2001-09-04 グプタ，アジャイ 水溶性ビタミン及び栄養素を含む透析溶液
EP0958832B1 (en) 1998-05-21 2006-01-25 Nipro Corporation Albumin containing peritoneal dialysis fluid
US7186420B2 (en) * 1999-04-26 2007-03-06 Edwards Lifesciences Corporation Multi-part substitution infusion fluids and matching anticoagulants
US8105258B2 (en) 1999-04-26 2012-01-31 Baxter International Inc. Citrate anticoagulation system for extracorporeal blood treatments
US6743191B1 (en) 1999-04-26 2004-06-01 Edwards Lifesciences Ag Substitution infusion fluid and citrate anticoagulation
US6627164B1 (en) * 2000-11-28 2003-09-30 Renal Solutions, Inc. Sodium zirconium carbonate and zirconium basic carbonate and methods of making the same
US7033498B2 (en) * 2000-11-28 2006-04-25 Renal Solutions, Inc. Cartridges useful in cleaning dialysis solutions
US6878283B2 (en) * 2001-11-28 2005-04-12 Renal Solutions, Inc. Filter cartridge assemblies and methods for filtering fluids
WO2003055481A1 (en) * 2001-12-25 2003-07-10 Ajinomoto Co., Inc. Organ fibrosis inhibitors
US20040121982A1 (en) * 2002-12-20 2004-06-24 Leo Martis Biocompatible dialysis fluids containing icodextrins
US20070155672A1 (en) * 2006-01-05 2007-07-05 Markus Voges Sterilized peritoneal dialysis solutions containing heparin
WO2009044765A1 (ja) * 2007-10-01 2009-04-09 Seikagaku Corporation 新規な低分子化コンドロイチン硫酸およびその用途
JP5652963B2 (ja) * 2009-03-31 2015-01-14 シーシーアイ株式会社 腹膜肥厚抑制剤
ITMI20120896A1 (it) 2012-05-23 2013-11-24 Bongulielmi Reto Condroitina per uso in medicina
EP3086824B1 (en) 2014-03-17 2018-10-31 Fresenius Medical Care Holdings, Inc. Cartridges useful in cleaning dialysis solutions
CA2991781C (en) 2015-09-16 2020-01-14 Fresenius Medical Care Holdings, Inc. Cartridges useful in cleaning dialysis solutions
EP3352586A4 (en) 2015-09-21 2019-05-15 The Board Of Trustees Of The Leland Stanford Junior University NUTRITIONAL TREATMENT FOR CANCER DISEASES
US10239847B1 (en) 2016-03-03 2019-03-26 Cellactin Method for 2-oxothiazolidine-4-carboxylic acid for cellular glutathione
EP3723772A4 (en) * 2017-12-11 2021-09-08 Filtricine, Inc. COMPOSITIONS, METHODS, KITS AND SYSTEMS FOR THE TREATMENT OF CANCER AND METABOLIC INTERVENTION THERAPY
GB202202728D0 (en) * 2022-02-28 2022-04-13 Invizius Ltd Peritoneal fluid composition

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2041377B (en) * 1979-01-22 1983-09-28 Woodroof Lab Inc Bio compatible and blood compatible materials and methods
US4339433A (en) * 1981-01-09 1982-07-13 Baxter Travenol Laboratories, Inc. Additives for peritoneal dialysis solutions
US4574085A (en) * 1981-05-15 1986-03-04 Baxter Travenol Laboratories, Inc. Method for using dialysis solution containing glycerol
US4761237A (en) * 1981-07-10 1988-08-02 Baxter Travenol Laboratories, Inc. Peritoneal dialysis solution containing carbohydrate polymers
US4886789A (en) * 1983-01-12 1989-12-12 M. L. Laboratories Plc Peritoneal dialysis and compositions for use therein
US4863907A (en) * 1984-06-29 1989-09-05 Seikagaku Kogyo Co., Ltd. Crosslinked glycosaminoglycans and their use
CA1239586A (en) * 1984-10-02 1988-07-26 Dimitrios G. Oreopoulos Dialysis solution containing amino acids
JPS61247466A (ja) * 1985-04-25 1986-11-04 テルモ株式会社 腹膜透析用透析液
GB8521712D0 (en) * 1985-08-31 1985-10-02 Giltech Ltd Solution for peritoneal dialysis
EP0218900B1 (en) * 1985-09-10 1992-01-22 Research Corporation Technologies, Inc. Osmotic agents for peritoneal dialysis
US4976683A (en) * 1986-06-20 1990-12-11 Abbott Laboratories Peritoneal dialysis method
GR870129B (en) * 1987-01-27 1987-02-04 Giatzidis Ippokratis Stable bicarbonate - glycylglycine dialysate for hemodialysis and peritoneal dialysis
DE3812525C1 (es) * 1988-04-15 1989-06-22 Fresenius Ag, 6380 Bad Homburg, De
JPH02196724A (ja) * 1989-01-26 1990-08-03 Terumo Corp 腹膜透析液
US5108767A (en) * 1991-06-10 1992-04-28 Abbott Laboratories Liquid nutritional product for persons receiving renal dialysis
ES2121941T3 (es) * 1992-02-04 1998-12-16 Baxter Int Soluciones de dialisis peritoneal y metodos utiles para reducir las lesiones y los efectos psicologicos negativos producidos por la peritonitis.

Also Published As

Publication number Publication date
DE69320078D1 (de) 1998-09-10
DE69332959T2 (de) 2004-05-13
JPH05345021A (ja) 1993-12-27
DK0555087T3 (da) 1999-05-03
EP0804931A2 (en) 1997-11-05
DE69320078T2 (de) 1999-03-25
EP0804931A3 (en) 2001-04-11
GR3027714T3 (en) 1998-11-30
JP3262620B2 (ja) 2002-03-04
ATE169223T1 (de) 1998-08-15
US5955450A (en) 1999-09-21
US5597805A (en) 1997-01-28
EP0555087A1 (en) 1993-08-11
DE69332959D1 (de) 2003-06-12
ATE239503T1 (de) 2003-05-15
EP0804931B1 (en) 2003-05-07
EP0555087B1 (en) 1998-08-05

Similar Documents

Publication Publication Date Title
ES2121941T3 (es) Soluciones de dialisis peritoneal y metodos utiles para reducir las lesiones y los efectos psicologicos negativos producidos por la peritonitis.
FR2639233B1 (fr) Agent d'hygiene en hemodialyse
AU6951087A (en) Pump block for interfacing irradiation chamber to photoactivation patient treatment system
AU6950387A (en) Light array assembly for photoactivation patient treatment system
JP2005509496A (ja) 装着型持続的腎機能代替療法装置
BR9405391A (pt) Processo para previnir hipotensão em paciente que recebe hemodiálise, processo e máquina para propiciar hemodiálise em paciente.
AU6950887A (en) Disposable temperature probe for photoactivation patient treatment system
ES2069728T5 (es) Un dispositivo respiratorio que comprende un soporte y un cambiador regenerativo de calor-humedad.
DE3851633D1 (de) Blutreinigungsvorrichtung.
CA2250919A1 (en) Photopheresis treatment of leukocytes
SE8502758D0 (sv) System for styrning av en medicinsk behandling, t ex dialys
GR3019495T3 (en) Blood-purifying equipment
NO940506D0 (no) Heterocykliske, substituerte fenyl-cykloheksan-karboksylsyrederivater
IE821162L (en) Dialysis solution
SE9600631D0 (sv) Use of a solution comprising glucose for peritonial dialysis having reduced formation of AGE products
Hommel et al. Multiple African honeybee stings and acute renal failure
DE69521388D1 (de) Verwendung von Glycosaminoglycanen zur Herstellung eines Arzneimittels zur Behandlung des chronischen Nierenversagens
ZA871410B (en) Zero insertion force socket for photoactivation patient treatment system
ATE251473T1 (de) Hämodialysegerät
PH24585A (en) Irradiation chamber for photoactivation patient treatment system
US20260007790A1 (en) Peritoneal dialysis disinfection device
DE69926311D1 (de) Notvorrichtung zum Trennen eines extrakorporellen Blutkreislaufs
Ross et al. Hyperpigmentation, bullae, and keratotic papules in a renal dialysis patient
Rhamy et al. Treatment of renal suppression associated with acute salicylate poisoning
BR8603841A (pt) Filtro de seguranca para equipos de transfusao de sangue,e solucoes parenterais

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 555087

Country of ref document: ES